TCT 2018 | PREPARE-CALC: Rotational Atherectomy vs. Cutting Balloon in Calcified Lesions

Compared against conventional predilation with balloon, rotational atherectomy is associated with higher procedural success rate in severely classified lesions. Balloons capable of modifying plaque such as the Flextome Cutting Balloon or the AngioSculpt Scoring Balloon -among others- could reach similar results to that of rotational atherectomy, though this has not been tested so far.

TCT 2018 | PREPARE-CALC: aterectomía rotacional vs Cutting Balloon en lesiones calcificadas200 patients with documented ischemia and severely calcified native coronary lesions were randomized to rotational atherectomy vs. cutting balloon in preparation to stenting, followed by sirolimus bioresorbable polymer-based DES implantation (Orsiro).

 

The study, presented at TCT 2018 and simultaneously publish in Circulation, had two primary end points: on the one hand, strategy success (successful stenting with <20% residual stenosis and TIMI 3 flow) and, on the other hand, late lumen loss at 9 months.


Read also: TCT 2018 | NEOPRO: A Registry for Acurate neo and Evolut PRO.


Procedural success was superior for rotational atherectomy (81% vs 98%; p=0.001) though with mean 5 more minutes of fluoroscopy time. Late lumen loss resulted non-inferior for both strategies. Need for revascularization and definite stent thrombosis rates were similar with both strategies.

 

Conclusion

Preparing severely calcified lesions with rotational atherectomy has higher procedural success than with cutting balloons. In time, operators will acquire the experience to know when to use rotational atherectomy and will learn to cross over when the simpler strategy won’t work.  

 

Original title: A Randomized Trial of High-Speed Rotational Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions.

Presenter: Gert Richardt.

 

PREPARE-CALC-presentación

PREPARE-CALC-artículo-original


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...